Security Snapshot

Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) Institutional Ownership

CUSIP: 83086J200

13F Institutional Holders and Ownership History from Q4 2023 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

41

Shares (Excl. Options)

16,023,081

Price

$0.69

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, par value $0.001
Symbol
SKYE on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
16,023,081
Latest holder snapshot 5 signals
Total 13F value
$11,108,567
Portfolio coverage rank
0%
Share change
-106,838
Value change
-$72,003
Number of holders
41
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
37,329,162
SEC-reported price per share
$0.28
Insider filing price
$0.28
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • SKYE - Skye Bioscience, Inc. - Common Stock, par value $0.001 is tracked under CUSIP 83086J200.
  • 41 institutions reported positions in Q2 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 36 to 41 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $9,913,850 to $11,108,567.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 41 institutions filings for Q2 2026.

Open SEC evidence

Security key

83086J200

13F reference period

Q2 2026

13F holders

41

13D/G owners

3

CIK / CUSIP context first

Open Q2 2026 holders SKYE full holder history Skye Bioscience, Inc. SEC filings Skye Bioscience, Inc. company facts Skye Bioscience, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
SKYE
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
5AM Partners VII, LLC 30% -11% $6,989,512 -$166,104 11,273,407 -2.3% Andrew J. Schwab 14 Aug 2026
SPHERA FUNDS MANAGEMENT LTD. 4.8% $2,952,706 1,476,353 Sphera Funds Management Ltd. 31 Mar 2025
Schonfeld Strategic Advisors LLC 3.6% -32% $4,441,437 -$1,996,997 1,115,939 -31% Schonfeld Strategic Advisors LLC 30 Jun 2025

As of 30 Jun 2026, 41 institutional investors reported holding 16,023,081 shares of Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE). This represents 43% of the company’s total 37,329,162 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
43%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
5AM Venture Management, LLC 26% 9,681,763 0% 2.3% $6,712,366
Versant Venture Management, LLC 5.4% 2,007,704 0% 0.86% $1,391,941
BAKER BROS. ADVISORS LP 4.2% 1,575,243 0% 0.01% $1,092,116
VANGUARD CAPITAL MANAGEMENT LLC 2% 763,882 -0.08% 0% $529,370
SPHERA FUNDS MANAGEMENT LTD. 1.8% 678,928 0% 0.07% $470,701
PLATINUM INVESTMENT MANAGEMENT LTD 0.62% 233,095 0% 0.04% $161,605
BlackRock, Inc. 0.62% 232,874 -19% 0% $161,452
GEODE CAPITAL MANAGEMENT, LLC 0.58% 218,055 -21% 0% $151,232
MILLENNIUM MANAGEMENT LLC 0.53% 198,524 -23% 0% $137,637
VANGUARD FIDUCIARY TRUST CO 0.28% 104,229 0% 0% $72,231
STATE STREET CORP 0.2% 73,830 -2% 0% $51,186
UBS Group AG 0.2% 73,800 +61% 0% $51,143
NORTHERN TRUST CORP 0.15% 56,327 +180% 0% $39,052
Qube Research & Technologies Ltd 0.12% 43,082 0% $29,869
SIMPLEX TRADING, LLC 0.07% 26,976 0% $18,702
XTX Topco Ltd 0.06% 20,993 -49% 0% $14,554
Engineers Gate Manager LP 0.05% 20,194 0% 0% $14,001
GROUP ONE TRADING LLC 0.01% 4,589 -36% 0% $3,182
Vanguard Global Advisers, LLC 0.01% 4,557 0% 0% $3,158
MORGAN STANLEY 0.01% 2,469 -3.1% 0% $1,711
BARCLAYS PLC 0% 655 -96% 0% $455
OSAIC HOLDINGS, INC. 0% 600 0% 0% $413
NATIONAL BANK OF CANADA /FI/ 0% 400 0% 0% $275
JPMORGAN CHASE & CO 0% 66 0% 0% $44
Zurcher Kantonalbank (Zurich Cantonalbank) 0% 52 0% 0% $36

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
12
Headline period
Q2 2026
Rows shown
1-12 of 12
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 0 $0 -$47 $0.28 0
2026 Q2 16,023,081 $11,108,567 -$72,003 $0.69 41
2026 Q1 16,129,917 $9,913,850 -$26,927 $0.61 36
2025 Q4 16,131,666 $12,093,567 -$11,627,173 $0.75 49
2025 Q3 19,883,163 $78,141,353 -$2,101,329 $3.93 56
2025 Q2 20,399,360 $85,269,369 -$12,432,557 $4.18 54
2025 Q1 24,700,100 $39,307,441 -$1,237,638 $1.59 72
2024 Q4 25,208,315 $71,310,457 -$3,219,919 $2.83 70
2024 Q3 25,729,728 $100,585,169 +$1,208,054 $3.91 72
2024 Q2 24,496,645 $196,252,371 +$179,861,577 $8.01 62
2024 Q1 2,009,303 $31,404,827 +$31,400,475 $15.64 3
2023 Q4 1,600 $4,352 $2.72 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .